Pricing Log in Create free account

Alpha Cognition Inc. (ACOG) vs BridgeBio Oncology Therapeutics, Inc (BBOT)

Alpha Cognition Inc. and BridgeBio Oncology Therapeutics, Inc are both Biotechnology companies. Alpha Cognition Inc. is the larger, with a market value of $180.5M against $163.6M — 1.1× the size. BridgeBio Oncology Therapeutics, Inc has the higher net margin (0.00% vs −137.7%) and the higher return on invested capital (−127.7% vs −144.7%). Across the 12 metrics below, Alpha Cognition Inc. leads on 6 and BridgeBio Oncology Therapeutics, Inc on 6.

Valuation

Metric ACOG BBOT Biotechnology median
P/E n/m n/m 10.60
P/S 11.83 n/m 9.40
P/B 3.41 0.51 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.31 0.66
EV/Sales 9.18 n/m 9.02
Earnings yield (11.58%) (135.29%) (32.88%)
Free cash flow yield (20.54%) (92.81%) (23.13%)

Profitability

Metric ACOG BBOT Biotechnology median
Gross margin 90.37% — 68.51%
Operating margin (174.70%) 0.00% 0.00%
Net margin (137.69%) 0.00% 0.00%
Free cash flow margin (242.99%) 0.00% 0.00%
Return on equity (49.53%) (252.10%) (51.96%)
Return on assets (38.33%) (96.69%) (46.06%)
Return on invested capital (144.65%) (127.66%) 0.00%

Growth

Metric ACOG BBOT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 42.08% 99.93% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACOG BBOT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 4.69 4.97
Net debt to EBITDA 2.92 2.93 1.01

Dividend

Metric ACOG BBOT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACOG BBOT Biotechnology median
Market cap 180.54m 163.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack